Why Choose Us Director's
Message Appointments Maps
& Directions Patient
Care & Support World-class Physicians Community Resources Cancer Information
Introduction
What
Are Clinical Trials? Phases
of Clinical Trials How
Are Clinical Trials Conducted? Clinical
Trials Safeguards Participating
in Clinical Trials The
Cost of Clinical Trials Finding
Specific Clinical Trials The
Future of Clinical Trials Search Available Clinical Trials
Eric R. Prossnitz, PhD
Co-Leader and Full Member
Women’s Cancers Research Program
Professor
Department of Cell Biology and Physiology
Education:
PhD at University of California at Berkeley
Post-doctoral fellowship at The Scripps Research Institute
Research focus (interests and expertise)
Estrogen-mediated signaling in cancer
Estrogen is a critical factor in many cancers and altering its activity through its many receptors is critical to the treatment of cancers. We are developing new approaches to diagnose and treat breast, endometrial and ovarian cancers based on the discovery of a new estrogen receptor named GPR30.